Ladenburg Thalmann Starts Sonoma Pharmaceuticals (SNOA) at Buy, 'Product and Geographic Expansion Continues to Grow Topline'
Tweet Send to a Friend
(Updated - September 5, 2023 6:49 AM EDT)
Ladenburg Thalmann analyst Jeff Cohen initiates coverage on Sonoma Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Ladenburg Thalmann analyst Jeff Cohen initiates coverage on Sonoma Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
